TrialContemporary clinical trials2021

Central monitoring in a randomized, open-label, controlled phase 3 clinical trial for a treatment-shortening regimen for pulmonary tuberculosis.

Kia E Bryant et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.